Skip to content
Sign in

ASTH · NASDAQ

Astrana Health (ASTH) Stock Price & Fundamentals

$698.00−0.58%−$4.04End-of-day price as of Oct 9, 2026

Astrana Health (ASTH) closed at $698.00 on Oct 9, 2026, down 0.58% from the previous close of $702.04.

Share price, past year

1Y +26.66%

52-week range $544.98 – $771.61. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$698.00
Sep 30, 2026$725.96
Aug 31, 2026$735.05
Jul 31, 2026$727.73
Jun 30, 2026$737.10
May 29, 2026$709.44
Apr 30, 2026$666.59
Mar 31, 2026$673.63
Feb 27, 2026$664.27
Jan 30, 2026$664.87
Dec 31, 2025$630.94
Nov 28, 2025$606.79
Oct 31, 2025$550.62

Key statistics

Market cap
$34.12B
P/E (TTM)
851.2
EPS (TTM)
$0.82
Revenue (TTM)
$3.84B
Net income (TTM)
$40.55M
Shares outstanding
48.9M
Dividend yield
—
52-week range
$544.98 – $771.61

Astrana Health's market cap is $34.12B, based on a share price of $698.00 and 48.9M shares outstanding as of Dec 31, 2025.

Financials

Astrana Health reported revenue of $3.18B for fiscal 2025, up 56.39% from fiscal 2024.

Astrana Health earned net income of $22.49M in fiscal 2025, a net margin of 0.7%.

Fiscal 2025 revenue was the highest in the 10 years shown.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Astrana Health annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$3.18B+56.4%$22.49M0.7%$0.46$104.49M
FY2024ended Dec 31, 2024$2.03B+46.7%$43.15M2.1%$0.90$44.17M
FY2023ended Dec 31, 2023$1.39B+21.2%$60.72M4.4%$1.29$39.70M
FY2022ended Dec 31, 2022$1.14B+47.8%$45.17M4.0%$0.99$59.19M
FY2021ended Dec 31, 2021$773.92M+12.6%$68.92M8.9%$1.52$51.11M
FY2020ended Dec 31, 2020$687.18M+22.6%$37.69M5.5%$1.01$45.00M
FY2019ended Dec 31, 2019$560.62M+7.8%$14.12M2.5%$0.39$12.63M
FY2018ended Dec 31, 2018$519.91M+805.3%$10.84M2.1%$0.29$24.33M
FY2017ended Mar 31, 2017$57.43M−81.2%−$8.97M−15.6%−$1.49—
FY2016ended Dec 31, 2016$305.93M—$11.45M3.7%$0.41$18.61M
Astrana Health quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$972.52M$19.74M$0.40
Q1 FY2026ended Mar 31, 2026$965.10M$14.44M$0.29
Q4 FY2025ended Dec 31, 2025$950.52M$6.00M$0.12
Q3 FY2025ended Sep 30, 2025$956.05M$373.00K$0.01
Q2 FY2025ended Jun 30, 2025$654.81M$9.42M$0.19
Q1 FY2025ended Mar 31, 2025$620.39M$6.69M$0.14
Q4 FY2024ended Dec 31, 2024$665.21M−$6.95M−$0.14
Q3 FY2024ended Sep 30, 2024$478.71M$16.09M$0.33

Company profile

Name
Astrana Health, Inc.
Ticker
ASTH
Exchange
NASDAQ
Industry (SEC SIC)
Services-Management Consulting Services
Headquarters
1668 S. Garfield Avenue, 2nd Floor, Alhambra, CA 91801
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0001083446

Recent SEC filings

Frequently asked questions

What is Astrana Health's stock price?

Astrana Health (ASTH) closed at $698.00 on Oct 9, 2026, down 0.58% from the previous close of $702.04.

What is Astrana Health's market cap?

Astrana Health's market cap is $34.12B, based on a share price of $698.00 and 48.9M shares outstanding as of Dec 31, 2025.

How much revenue does Astrana Health make?

Astrana Health reported revenue of $3.18B for fiscal 2025, up 56.39% from fiscal 2024.

What is ASTH's P/E ratio?

Astrana Health's price-to-earnings ratio is 851.2, based on trailing twelve-month diluted EPS of $0.82.

Does Astrana Health pay a dividend?

Astrana Health's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Astrana Health, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures